TFF PHARMACEUTICALS
TFF Pharmaceuticals an early-stage biopharmaceutical company focused on developing and commercializing innovative drug products for the treatment of lung diseases and conditions. TFF Pharmaceuticals has generated numerous formulations for faster and more complete dry powder delivery to the lungs.
TFF PHARMACEUTICALS
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2018-01-24
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.tffpharma.com
Total Employee:
11+
Status:
Active
Contact:
215-880-2632
Total Funding:
72.87 M USD
Technology used in webpage:
IPv6 JQuery CDN Amazon S3 Akamai Hosted Amazon API Gateway
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Peroxitech Therapeutics
Peroxitech Therapeutics operates as a biopharmaceutical company.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Current Advisors List
Current Employees Featured
Stock Details
Investors List
National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Diseases investment in Grant - TFF Pharmaceuticals
Leidos holdings
Leidos holdings investment in Post-IPO Equity - TFF Pharmaceuticals
Liquid Ventures
Liquid Ventures investment in Series A - TFF Pharmaceuticals
Liquid Ventures
Liquid Ventures investment in Series A - TFF Pharmaceuticals
Key Employee Changes
Official Site Inspections
http://www.tffpharma.com Semrush global rank: 7.04 M Semrush visits lastest month: 916
- Host name: 209.182.196.37
- IP address: 209.182.196.37
- Location: Los Angeles United States
- Latitude: 33.956
- Longitude: -118.3887
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90045
More informations about "TFF Pharmaceuticals"
Transforming How Medicines are Developed and Delivered to …
[email protected]. The treating physician is responsible for obtaining local regulatory approval for the investigational use. Depth and Breadth of Partnerships TFF …See details»
TFF Pharmaceuticals - Crunchbase Company Profile & Funding
TFF Pharmaceuticals may be growing as the company has surpassed expectations with its third quarter 2023 earnings. The financial results indicate a positive trajectory, with earnings that …See details»
TFF Pharmaceuticals Receives Approval from Health Canada to
Oct 28, 2021 World Health Organization; Geneva: 2007. The Selection and Use of Essential Medicines. Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved …See details»
TFF Pharmaceuticals, Inc. (TFFP) Company Profile & Overview
Oct 25, 2019 1751 River Run, Suite 400 Fort Worth, Texas 76107 United StatesSee details»
Programs | TFF Pharmaceuticals
[email protected] 817-415-0060. Partnered Programs. Learn more about additional collaborations with our biopharma, academic, government and CDMO partners. …See details»
TFF Pharmaceuticals Enters into Worldwide Licensing Agreement …
Aug 13, 2020 Glenn Mattes President and CEO TFF Pharmaceuticals, Inc. [email protected] 737-802-1973 Kirk Coleman Chief Financial Officer TFF …See details»
TFF Pharmaceuticals Enters into Worldwide Licensing Agreement …
Glenn Mattes President and CEO TFF Pharmaceuticals, Inc. [email protected] 737-802-1973. Kirk Coleman Chief Financial Officer TFF Pharmaceuticals, Inc. …See details»
TFF Pharmaceuticals Inc Company Profile - GlobalData
Website tffpharma.com No of Employees 19. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange TFFP (NASD) Revenue (2022) $733,900 48% (2022 vs 2021) EPS XYZ. …See details»
TFF Pharmaceuticals Enters into CRADA with the National Institute …
May 4, 2023 To learn more about TFF Pharmaceuticals and its product candidates, visit the Company’s website at https://tffpharma.com. SAFE HARBOR This press release contains …See details»
TFF Pharmaceuticals & Catalent Partner for Inhalation Dry Powder
Mar 1, 2022 [email protected]. Kirk Coleman +1 (817) 989 6358 [email protected]. Media Contact: Gwendolyn Schanker LifeSci Communications +1 …See details»
TFF Pharmaceuticals - Craft
Oct 29, 2024 TFF Pharmaceuticals has 4 employees at their 1 location and $733.87 k in annual revenue in FY 2023. See insights on TFF Pharmaceuticals including office locations, …See details»
TFF Pharmaceuticals Hosting Key Opinion Leader Perspectives on …
Jun 7, 2021 To learn more about TFF Pharmaceuticals and its product candidates, visit the Company’s website at https://tffpharma.com. Company Contacts: Glenn Mattes President and …See details»
TFF Pharmaceuticals Receives Approval from Health Canada to …
Oct 28, 2021 First Patient in Phase 1 Trial to be Dosed in November with Enrollment Completion Anticipated by Early Q1 2022 Preclinical Studies of Inhaled Dry Powder Formulation of …See details»
TFF Pharmaceuticals Enters into CRADA with the U.S. Army and …
Mar 17, 2022 To learn more about TFF Pharmaceuticals and its product candidates, visit the Company’s website at https://tffpharma.com ... The Geneva Foundation is a 501(c)3 non-profit …See details»
TFF Pharmaceuticals Announces Update on Clinical Programs
Mar 20, 2024 The call will also be broadcast live over the Web and can be accessed on TFF Pharmaceuticals’ Website, https://tffpharma.com or directly at ...See details»
TFF Pharmaceuticals Reports Fourth Quarter 2022 and Full
Jul 3, 2023 [email protected]. Investor Relations Contact: Corey Davis, Ph.D. LifeSci Advisors (212) 915-2577 [email protected]. Media Contact: Raena Mina LifeSci …See details»
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2021 …
Mar 24, 2022 [email protected]. Kirk Coleman Chief Financial Officer TFF Pharmaceuticals, Inc. [email protected]. Investor Relations Contact: Corey Davis, …See details»
TFF Pharmaceuticals Announces Positive Initial Data from ... - Nasdaq
Dec 19, 2023 --TFF Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film …See details»
TFF Pharmaceuticals Reports Third Quarter 2021 Financial
Nov 15, 2021 [email protected] 817-989-6358. Investor Relations Contact: Corey Davis, Ph.D. LifeSci Advisors 212-915-2577 [email protected] Media Contact: ...See details»
TFF Pharmaceuticals Announces Final Data from Phase 1b
Dec 21, 2021 Final Safety and Pharmacokinetic Data Continue to Support Progression to Phase 2 in the Near Term for Treatment of Invasive Pulmonary Aspergillosis (IPA),...See details»